Martin P. Dybek. Stock Analysis on Net

Martin P. Dybek
Financial Analyst
Stock Analysis on Net

If you are a successful investor, you are able to take advantage of their potential for extraordinary profit, you always buy undervalued companies cheap and sell them expensive after their price has risen, you don't need to go inside. You will certainly not be interested in Stock Analysis on Net.

Today, try for free:

Bristol-Myers Squibb Co.

Financial statements analysis and stock valuation

Statement of Cash Flows

The cash flow statement provides information about Bristol-Myers Squibb Co.'s cash receipts and cash payments during an accounting period, showing how these cash flaws link the ending cash balance to the beginning balance shown on Bristol-Myers Squibb Co.'s statement of financial position.

Capital Asset Pricing Model (CAPM)

CAPM is a theory concentrated with deriving the expected rates of return on risky assets based on the assets' systematic risk levels. Systematic risk is the variability of returns that is due to macroeconomic factors that affect all risky assets. It cannot be eliminated by diversification.

Enterprise Value to EBITDA (EV/EBITDA)

To calculate EBITDA analysts start with net earnings. To that earnings number, interest, taxes, depreciation, and amortization are added. EBITDA as a pre-interest number is a flow to all providers of capital.

Income Statement (Quarterly Data)

The income statement (statement of earnings) reports on the performance of Bristol-Myers Squibb Co., the result of its operating activities.

More »